Showing results (271-280 of 781) with videos related to
Sort By:
Pageof 79
Cardiology in Review|July 29, 2024
A Review of Sotagliflozin: The First Dual SGLT-1/2 InhibitorZoya Siddiqui, Niloofar Rasouli, Eliana Felder, et al.Cardiology in Review|April 22, 2025
Antibody ALXN2220 (Formerly NI006) for the Treatment of Transthyretin Cardiac AmyloidosisAshwin A Pillai, William H Frishman, Wilbert S AronowCardiology in Review|March 17, 2025
Advances in Atrial Septal Defect Closure: Managing Pulmonary Hypertension and Expanding Treatment Criteria ApplicabilityMalkiel R Frager, William H Frishman, Wilbert S AronowCardiology in Review|March 6, 2025
The Role of Tongxinluo Capsule in Cardiac Disease: Composition, Mechanisms, and ApplicationsBen Barris, Avrohom Karp, Menachem Jacobs, et al.Nature Reviews. Cardiology|October 28, 2010
Cardiovascular drug therapy in the elderly: benefits and challengesJerome L Fleg, Wilbert S Aronow, William H FrishmanVascular Health and Risk Management|April 2, 2009
Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunctionWilliam H Frishman, Linda S Henderson, Mary Ann LukasCardiology in Review|September 13, 2012
Vascular and heart diseases in the incumbent presidents and vice presidents of the United States of america: a medical-historical perspectiveWilliam H Frishman, Franklin H Zimmerman, Robert G LernerCardiology in Review|June 22, 2012
Renal sympathetic denervation for the treatment of systemic hypertensionGordon M Burke, Domenic A Sica, William H FrishmanCardiology in Review|February 24, 2006
Nicotine and non-nicotine smoking cessation pharmacotherapiesWilliam H Frishman, Walter Mitta, Adam Kupersmith, et al.Cardiology in Review|November 6, 2024
Implementing a Comprehensive CPR Education in New York State Public High Schools: Ideas, Drawbacks, & Future DirectionsHarris Z Whiteson, Prakash Poudel Jaishi, William H FrishmanPageof 79